Variability in total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) is associated with dementia and cognitive impairment.

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.

Dental flossing is associated with a lower risk for ischemic and cardioembolic stroke and atrial fibrillation (AF).

Heat-related deaths are expected to climb throughout Europe this century due to climate change, according to a study published online.

Parental sociodemographic characteristics and COVID-19 vaccination status are associated with measles-mumps-rubella (MMR) vaccination rates in the United States.

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Opioid-related neurocognitive symptoms among patients on long-term opioid therapy were most prevalent during the course of therapy.

Among patients with chronic insomnia, transcutaneous auricular vagus nerve stimulation improves sleep quality and is safe and effective.

A total of 62.7% of patients expressed the desire to be notified about the use of artificial intelligence (AI) in patient care.

Referral to a specialized, comprehensive functional seizures treatment clinic is linked to reduced health care costs and utilization.